These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7685028)
21. Evidence that the heparin-binding consensus sequence of vitronectin is recognized by Staphylococcus aureus. Liang OD; Flock JI; Wadström T J Biochem; 1994 Aug; 116(2):457-63. PubMed ID: 7529761 [TBL] [Abstract][Full Text] [Related]
22. Localization of 13-hydroxyoctadecadienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro. Buchanan MR; Bertomeu MC; Haas TA; Orr FW; Eltringham-Smith LL Blood; 1993 Jun; 81(12):3303-12. PubMed ID: 7685202 [TBL] [Abstract][Full Text] [Related]
23. Localization of two binding domains for thrombospondin within fibronectin. Zafar RS; Zeng Z; Walz DA Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347 [TBL] [Abstract][Full Text] [Related]
24. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. Agbanyo FR; Sixma JJ; de Groot PG; Languino LR; Plow EF J Clin Invest; 1993 Jul; 92(1):288-96. PubMed ID: 7686921 [TBL] [Abstract][Full Text] [Related]
25. Evidence that conformational changes upon the transition of the native to the modified form of vitronectin are not limited to the heparin binding domain. Seiffert D FEBS Lett; 1995 Jul; 368(1):155-9. PubMed ID: 7542204 [TBL] [Abstract][Full Text] [Related]
26. Activation of human neutrophils increases thrombospondin receptor expression. Suchard SJ; Boxer LA; Dixit VM J Immunol; 1991 Jul; 147(2):651-9. PubMed ID: 1712815 [TBL] [Abstract][Full Text] [Related]
27. Human carcinoma cells express receptors for distinct domains of thrombospondin. Yabkowitz R; Dixit VM Cancer Res; 1991 Mar; 51(6):1645-50. PubMed ID: 1705477 [TBL] [Abstract][Full Text] [Related]
28. Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. de Boer HC; Preissner KT; Bouma BN; de Groot PG J Biol Chem; 1992 Feb; 267(4):2264-8. PubMed ID: 1370815 [TBL] [Abstract][Full Text] [Related]
29. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor. Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B Biochem Biophys Res Commun; 1994 Oct; 204(1):325-32. PubMed ID: 7524499 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of fibronectin matrix assembly by the heparin-binding domain of vitronectin. Hocking DC; Sottile J; Reho T; Fässler R; McKeown-Longo PJ J Biol Chem; 1999 Sep; 274(38):27257-64. PubMed ID: 10480945 [TBL] [Abstract][Full Text] [Related]
33. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057 [TBL] [Abstract][Full Text] [Related]
34. Novel effect of cyclicization of the Arg-Gly-Asp-containing peptide on vitronectin binding to platelets. Mohri H; Hashimoto Y; Ohba M; Kumagai H; Ohkubo T Am J Hematol; 1991 May; 37(1):14-9. PubMed ID: 1708943 [TBL] [Abstract][Full Text] [Related]
36. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317 [TBL] [Abstract][Full Text] [Related]
37. Ligation of integrin alpha5beta1 is required for internalization of vitronectin by integrin alphavbeta3. Pijuan-Thompson V; Gladson CL J Biol Chem; 1997 Jan; 272(5):2736-43. PubMed ID: 9006912 [TBL] [Abstract][Full Text] [Related]
38. Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex. Høgåsen K; Mollnes TE; Harboe M J Biol Chem; 1992 Nov; 267(32):23076-82. PubMed ID: 1385412 [TBL] [Abstract][Full Text] [Related]
39. Binding of vitronectin and plasminogen to Helicobacter pylori. Ringnér M; Valkonen KH; Wadström T FEMS Immunol Med Microbiol; 1994 Jun; 9(1):29-34. PubMed ID: 7522734 [TBL] [Abstract][Full Text] [Related]
40. A peptide corresponding to GPIIb alpha 300-312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin GPIIb/IIIa, inhibits the adhesion of platelets to at least four adhesive ligands. Taylor DB; Gartner TK J Biol Chem; 1992 Jun; 267(17):11729-33. PubMed ID: 1376310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]